THERMOCOOL SMARTTOUCH™ Catheter
THERMOCOOL SMARTTOUCH™ Catheter
Deliver a measure of success to your cardiac arrhythmia patients with the THERMOCOOL SMARTTOUCH™ Catheter. The Catheter’s stability results in more consistent contact force, producing more uniform lesions.
A single center study has shown up to 92% success rate at 1-year follow up.¹
MEDIA
Deliver a measure of success to your cardiac arrhythmia patients with the THERMOCOOL SMARTTOUCH™ Catheter. The Catheter’s stability results in more consistent contact force, producing more uniform lesions.
A single center study has shown up to 92% success rate at 1-year follow up.¹
Features & Benefits
Visualisation
- Provides consistent movement in response to contact force using precision spring
- Sends accurate location reference signal via location sensor and transmitter coil2
Visualisation
- Promotes consistent lesion formation3
- Reduces ablation time*4
- Improves outcomes with more stable catheter-tissue contact force5
Available in bidirectional platform
Supporting Documentation
Resources
References
*29% reduction in ablation time compared to NAVISTAR® THERMOCOOL® Catheter
- Taghji P, El Haddad M, Phlips T , et al Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation . A pilot study. J Am Coll cardiol EP January 01, 2018, 4 (1) 99-108
- CARTO User Guide, UG-5400-007H
- Chinitz LA, Melby DP, Marchlinski FE, Delaughter C, Fishel RS et al. (2017) Safety and efficiency of porous‐tip contactforce catheter for drug‐refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. J Ep Europace 20 (FI_3): f392‐f400.
- Martinek M, Lemes C, Sigmund E, et al. Clinical impact of an open-irrigated radiofrequency catheter with direct force measurement on atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35(11):1312-1318.
- Kumar S, Morton JB, Lee J, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5:1124-1129.
Indication Statement
Important information: For product details such as indications, contraindications, warnings and precautions please consult the IFU.
117169-211018
© Johnson & Johnson Medical Limited 2021. All Rights Reserved.
This site is published by Biosense Webster, Inc. which is solely responsible for its contents. This site is for visitors from the United Kingdom and Ireland.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.
©Biosense Webster, Inc. 2020 Last Updated on 1/5/20.
